Home › Brain Hypoxia-Ischemia › NCT07628829

Neonatal Neurological Observation With Video AI

Who can join

All ages · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Signed and dated informed consent from at least one parent or legally authorized representative (LAR) who is at least 18 years old.
* Parent/LAR expresses willingness to comply with study procedures for the duration of the infant's hospital stay.
* Infant of any sex (including intersex/undetermined) admitted to newborn services (including the NICU) at a participating hospital.

Exclusion Criteria:

* Parents or LAR unable to provide informed consent or are under the age of 18.
* Non-viable neonates

About the study

NeoNOVA is a multi-site, prospective, single-arm, silent observational study to determine: among (Population) infants admitted to newborn services during their inpatient hospital stay, whether (Intervention) continuous bedside non-contact high definition video running real-time AI analysis of anatomic landmarks and movement, (Comparison) compared against human-labeled video frames and standardized clinical exams, will (Outcome) accurately localize infant anatomic landmarks (primary objective; outcome median position error in pixels) and demonstrate a statistically significant association between a video-derived movement index and clinical measures of patient neurological exams (secondary objective; outcomes N-PASS and modified Sarnat exams).

What is being tested

• Continuous bedside video monitoring with AI anatomic landmark tracking for neurologic monitoring (device)

Sponsor: Artemis AI Labs · Participants: 200 · Started: Jul 13, 2026

Contact the study team

• Saum Naderi, MA · Phone: 714-913-3641
• Florian Richter, PhD · Phone: 773-312-3301

Official record on ClinicalTrials.gov — NCT07628829

Locations in the U.S.

Conditions

• Brain Hypoxia-Ischemia
• Brain Diseases

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.